Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-08-19

FDA Approved: ATORVASTATIN CALCIUM — Original Application (NIVAGEN PHARMACEUTICALS, INC.)

View source ↗

Summary

FDA approves an original new application for atorvastatin calcium from NIVAGEN Pharmaceuticals, a generic version of atorvastatin indicated for treating high ch…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ATORVASTATIN CALCIUM (atorvastatin calcium)

Snippet

ORIG AP for ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM)